2024 annual financial data
BioRestorative Therapies 2024 Operating margin
Direct answer
Operating margin was -2,881.59%.
Operating income was -11,555,194 USD and net income was -8,979,381 USD.
Operating cash flow was -8,230,346 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 401,000 USD
- Operating income
- -11,555,194 USD
- Net income
- -8,979,381 USD
- Operating cash flow
- -8,230,346 USD